SNC
CELG

Stifel Nicolaus & Co’s Celgene Corp CELG Stock Holding History

Stifel Nicolaus & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$5.29M Sell
68,622
-4,464
-6% -$313K 0.09% 222
2013
Q2 		$4.27M Buy
+73,086
New +$4.4M 0.08% 241

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Stifel Nicolaus & Co's CELG Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its Celgene Corp (CELG) stake by 6.1% in Q3 2013, selling an estimated $313K and leaving 68,622 shares worth $5.29M. The position accounts for 0.09% of the portfolio, ranked #222.

Stifel Nicolaus & Co first reported a position in CELG in Q2 2013 and has held it in 2 quarters since. 909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

  • Stifel Nicolaus & Co held 68,622 shares of Celgene Corp worth $5.29M as of Q3 2013.
  • Stifel Nicolaus & Co sold 4,464 Celgene Corp shares in Q3 2013, an estimated $313K.
  • Celgene Corp made up 0.09% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #222 holding.
  • Stifel Nicolaus & Co first reported a position in Celgene Corp in Q2 2013 and has held it in 2 quarters since.
  • 909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.